Rep. Julie Johnson Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Rep. Julie Johnson sold between $1,001 and $15,000 of UnitedHealth Group (UNH) stock on November 13 via her Chase brokerage account and executed similar-sized sales in multiple other large-cap names the same day.
• UnitedHealth reported Q3 EPS of $2.92 (beating estimates) and revenue of $113.16B (up 12.2% YoY), and declared a $2.21 quarterly dividend payable Dec. 16 (ex-dividend Dec. 8), implying a ~2.6% yield.
• The stock is trading modestly higher (about +1.5%), with a market cap near $310B and a P/E around 17.8, while analysts' consensus is a "Hold" with an average price target of $385.54 and mixed ratings distribution.

Representative Julie Johnson (D-Texas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on November 13th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Cigna Group NYSE: CI on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Xcel Energy NASDAQ: XEL on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Walmart NASDAQ: WMT on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Wells Fargo & Company NYSE: WFC on 11/13/2025.
• Sold $1,001 - $15,000 in shares of Texas Instruments NASDAQ: TXN on 11/13/2025.
• Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 11/13/2025.
• Sold $1,001 - $15,000 in shares of American Express NYSE: AXP on 11/13/2025.

UnitedHealth Group Trading Up 1.5%

UNH stock opened at $341.83 on Monday. The company has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The business has a 50 day simple moving average of $339.84 and a two-hundred day simple moving average of $317.20.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts' consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group's revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $7.15 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's payout ratio is currently 46.14%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. Wells Fargo & Company raised their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a research report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $333.00 price objective on the stock. in a research note on Wednesday, October 29th. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an "overweight" rating in a report on Thursday, October 9th. Royal Bank Of Canada upped their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an "outperform" rating in a research note on Wednesday, October 29th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Seventeen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of "Hold" and a consensus price target of $385.54.

Hedge Funds Weigh In On UnitedHealth Group

Large investors have recently made changes to their positions in the company. LFA Lugano Financial Advisors SA bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $25,000. Bayforest Capital Ltd boosted its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth $29,000. Foster Dykema Cabot & Partners LLC grew its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 34 shares during the last quarter. Finally, 1248 Management LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at about $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.